Relay Therapeutics, Inc.RLAYNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | -23.26% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | -23.26% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +36.52% | +29.34% | +28.94% | +22.93% | +2.54% |
| Weighted Average Shares Diluted Growth | +36.52% | +29.34% | +28.94% | +22.93% | +2.54% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +3.24% | -5.00% | -5.66% | -27.97% | -28.69% |
| Book Value per Share Growth | -24.24% | -25.24% | -24.28% | -41.07% | -28.90% |
| Debt Growth | -9.28% | -9.84% | -33.10% | -33.09% | -33.08% |
| R&D Expense Growth | -12.16% | -10.43% | -30.54% | -10.91% | -18.60% |
| SG&A Expenses Growth | +0.82% | -5.35% | -32.34% | -42.37% | -23.31% |